Browse > Article
http://dx.doi.org/10.5125/jkaoms.2022.48.3.131

Post-acute infection syndrome after COVID-19: effects on the oral and maxillofacial region and the recent publication trends  

Park, Joo-Young (Department of Oral and Maxillofacial Surgery, Seoul National University Dental Hospital, School of Dentistry, Seoul National University)
Publication Information
Journal of the Korean Association of Oral and Maxillofacial Surgeons / v.48, no.3, 2022 , pp. 131-132 More about this Journal
Keywords
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 World Health Organization (WHO). WHO coronavirus (COVID-19) dashboard [Internet]. Geneva: WHO [cited 2022 Jun 1]. Available from: https://covid19.who.int/.
2 Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med 2022;28:911-23. https://doi.org/10.1038/s41591-022-01810-6   DOI
3 Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, et al. Short-term and Long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open 2021;4:e2128568. https://doi.org/10.1001/jamanetworkopen.2021.28568   DOI
4 Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-Month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021;397:220-32. https://doi.org/10.1016/S0140-6736(20)32656-8   DOI
5 Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med 2021;18:e1003773. https://doi.org/10.1371/journal.pmed.1003773   DOI
6 Hickie I, Davenport T, Wakefield D, Vollmer-Conna U, Cameron B, Vernon SD, et al.; Dubbo Infection Outcomes Study Group. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ 2006;333:575. https://doi.org/10.1136/bmj.38933.585764.AE   DOI
7 Ali IE, Chugh A, Cheewin T, Hattori M, Sumita YI. The rising challenge of mucormycosis for maxillofacial prosthodontists in the Covid-19 pandemic: a literature review. J Prosthodont Res 2022. https://doi.org/10.2186/jpr.JPR_D_21_00264 [Epub ahead of print]   DOI
8 Kumar M, Sarma DK, Shubham S, Kumawat M, Verma V, Singh B, et al. Mucormycosis in COVID-19 pandemic: risk factors and linkages. Curr Res Microb Sci 2021;2:100057. https://doi.org/10.1016/j.crmicr.2021.100057   DOI
9 Fakhruddin KS, Samaranayake LP, Buranawat B, Ngo H. Orofacial mucocutaneous manifestations of coronavirus disease-2019 (COVID-19): a systematic review. PLoS One 2022;17:e0265531. https://doi.org/10.1371/journal.pone.0265531   DOI
10 Bhargava D, Ahirwal R, Dubey S, Gurjar P, Pandey A, Beena S, et al. COVID induced functional exhaustion and persistently reduced lymphocytes as vital contributing factors for post-COVID rhino-orbital and cerebral mucormycosis in patients with diabetes: report from the Indian sub-continent. Head Neck Pathol 2021. https://doi.org/10.1007/s12105-021-01382-w [Epub ahead of print]   DOI
11 Gupta S, Saarikko M, Pfutzner A, Raisanen IT, Sorsa T. Compromised periodontal status could increase mortality for patients with COVID-19. Lancet Infect Dis 2022;22:314. https://doi.org/10.1016/S1473-3099(22)00065-2   DOI
12 Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep 2021;11:16144. https://doi.org/10.1038/s41598-021-95565-8   DOI
13 Manon VA, Balandran S, Young S, Wong M, Melville JC. COVID-associated avascular necrosis of the maxilla-a rare, new side effect of COVID-19. J Oral Maxillofac Surg 2022. https://doi.org/10.1016/j.joms.2022.04.015 [Epub ahead of print]   DOI
14 Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci 2020;12:8. https://doi.org/10.1038/s41368-020-0074-x   DOI
15 Bergwerk M, Gonen T, Lustig Y, Amit S, Lipsitch M, Cohen C, et al. Covid-19 breakthrough infections in vaccinated health care workers. N Engl J Med 2021;385:1474-84. https://doi.org/10.1056/NEJMoa2109072   DOI
16 Balushi AA, Ajmi AA, Sinani QA, Menon V, Berieki ZA, Shezawi AA, et al. COVID-19-associated mucormycosis: an opportunistic fungal infection. A case series and review. Int J Infect Dis 2022;121:203-10. https://doi.org/10.1016/j.ijid.2022.05.005   DOI
17 Garg D, Muthu V, Sehgal IS, Ramachandran R, Kaur H, Bhalla A, et al. Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature. Mycopathologia 2021;186:289-98. https://doi.org/10.1007/s11046-021-00528-2   DOI
18 Sharma S, Grover M, Bhargava S, Samdani S, Kataria T. Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum. J Laryngol Otol 2021;135:442-7. https://doi.org/10.1017/S0022215121000992   DOI
19 Al-Mahalawy H, El-Mahallawy Y, Dessoky NY, Ibrahim S, Amer H, Ayad HM, et al. Post-COVID-19 related osteonecrosis of the jaw (PC-RONJ): an alarming morbidity in COVID-19 surviving patients. BMC Infect Dis 2022;22:544. https://doi.org/10.1186/s12879-022-07518-9   DOI